Eva Szigethy is a Psychiatry physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3811 Ohara St
Pittsburgh, PA 152132561
Telephone
412-624-1000Provider last certified this registry record 9 Mar 2023.
Clinical trials
- Addressing Cognitive Fog in Long-COVID-19 Patients
Sponsor: Eva Szigethy
- Study to Compare the Use of a Behavioral Health App Versus Care As Usual for 16-22 Year Olds with Depression
Sponsor: University of Pittsburgh
- Specialty Medical Homes to Improve Outcomes for Patients With IBD and Behavioral Health Conditions
Sponsor: University of Pittsburgh
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%SSRI29.8%Escitalopram Oxalate37%Trazodone Hcl24%Sertraline Hcl22%Paroxetine Hcl17%Part D<11 patientsAtypical Antipsychotic20.8%Quetiapine Fumarate77%Quetiapine Fumarate Er23%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2004–2012 per NIH RePORTER. The latest:
- Reducing Depressive Symptoms in Physically Ill Youth
University of Pittsburgh at Pittsburgh
FY2012$486,442R01MH077770 - Reducing Depressive Symptoms in Physically Ill Youth
University of Pittsburgh at Pittsburgh
FY2011$605,651R01MH077770 - Reducing Depressive Symptoms in Physically Ill Youth
University of Pittsburgh at Pittsburgh
FY2010$675,265R01MH077770
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”